Literature DB >> 23292860

Importance of detecting multidrug resistance proteins in acute leukemia prognosis and therapy.

Ana Carolina Rabello de Moraes1, Caroline Klein Maranho, Gabriela Schneider Rauber, Maria Cláudia Santos-Silva.   

Abstract

Multidrug resistance (MDR) is a multifactorial phenomenon and the role of these proteins in generating the MDR phenotype is controversial. With this in mind, this review compiled the current data on the role of ABCB1, ABCC1, and LRP proteins in the prognosis of hematologic neoplasms and their influence on the choice of therapy. Literature showed that the detection of these proteins, mainly ABCB1, is important in the AL prognosis. However, there is controversy regarding the methodology used for their detection. In summary, the expression and activity profiles of ABCB1, ABCC1, and LRP, proteins capable of promoting the efflux of a variety of chemotherapeutic agents from the cell cytoplasm represent one of the greatest causes of failure in AL treatment.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23292860      PMCID： PMC6807608          DOI： 10.1002/jcla.21563

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN： 0887-8013            Impact factor:   2.352


  93 in total

Review 1.  The human ATP-binding cassette (ABC) transporter superfamily.

Authors:  M Dean; A Rzhetsky; R Allikmets
Journal:  Genome Res       Date:  2001-07       Impact factor: 9.043

2.  Predictive value of multidrug resistance proteins and cellular drug resistance in childhood relapsed acute lymphoblastic leukemia.

Authors:  Jan Styczynski; Mariusz Wysocki; Robert Debski; Krzysztof Czyzewski; Beata Kolodziej; Beata Rafinska; Malgorzata Kubicka; Sylwia Koltan; Andrzej Koltan; Monika Pogorzala; Andrzej Kurylak; Dorota Olszewska-Slonina; Walentyna Balwierz; Edyta Juraszewska; Maria Wieczorek; Igor Olejnik; Maryna Krawczuk-Rybak; Marta Kuzmicz; Jerzy Kowalczyk; Jolanta Stefaniak; Wanda Badowska; Danuta Sonta-Jakimczyk; Tomasz Szczepanski; Michal Matysiak; Iwona Malinowska; Elzbieta Stanczak; Jacek Wachowiak; Benigna Konatkowska; Lidia Gil; Anna Balcerska; Lucyna Maciejka-Kapuscinska
Journal:  J Cancer Res Clin Oncol       Date:  2007-08-02       Impact factor: 4.553

3.  Solution structure of a two-repeat fragment of major vault protein.

Authors:  Guennadi Kozlov; Olga Vavelyuk; Ovidiu Minailiuc; Denis Banville; Kalle Gehring; Irena Ekiel
Journal:  J Mol Biol       Date:  2005-12-07       Impact factor: 5.469

4.  Multidrug resistance proteins MRP3, MRP1, and MRP2 in lung cancer: correlation of protein levels with drug response and messenger RNA levels.

Authors:  L C Young; B G Campling; S P Cole; R G Deeley; J H Gerlach
Journal:  Clin Cancer Res       Date:  2001-06       Impact factor: 12.531

Review 5.  Flip-flop: the transmembrane translocation of lipids.

Authors:  C F Higgins
Journal:  Cell       Date:  1994-11-04       Impact factor: 41.582

Review 6.  Mechanisms of drug resistance in cancer chemotherapy.

Authors:  Y A Luqmani
Journal:  Med Princ Pract       Date:  2005       Impact factor: 1.927

7.  Effects of various methoxyflavones on vincristine uptake and multidrug resistance to vincristine in P-gp-overexpressing K562/ADM cells.

Authors:  Hisakazu Ohtani; Tomomi Ikegawa; Youko Honda; Noriko Kohyama; Satoshi Morimoto; Yukihiro Shoyama; Motoharu Juichi; Mikihiko Naito; Takashi Tsuruo; Yasufumi Sawada
Journal:  Pharm Res       Date:  2007-05-10       Impact factor: 4.200

Review 8.  Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia.

Authors:  L S Steelman; S L Abrams; J Whelan; F E Bertrand; D E Ludwig; J Bäsecke; M Libra; F Stivala; M Milella; A Tafuri; P Lunghi; A Bonati; A M Martelli; J A McCubrey
Journal:  Leukemia       Date:  2008-03-13       Impact factor: 11.528

Review 9.  Acute myelogenous leukemia.

Authors:  Joshua L Shipley; James N Butera
Journal:  Exp Hematol       Date:  2009-06       Impact factor: 3.084

10.  Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: a study in serial samples.

Authors:  Richard T Penson; Esther Oliva; Steven J Skates; Tina Glyptis; Arlan F Fuller; Annekathryn Goodman; Michael V Seiden
Journal:  Gynecol Oncol       Date:  2004-04       Impact factor: 5.482
View more
  10 in total

Review 1.  Harnessing the power of sphingolipids: Prospects for acute myeloid leukemia.

Authors:  Johnson Ung; Su-Fern Tan; Todd E Fox; Jeremy J P Shaw; Luke R Vass; Pedro Costa-Pinheiro; Francine E Garrett-Bakelman; Michael K Keng; Arati Sharma; David F Claxton; Ross L Levine; Martin S Tallman; Myles C Cabot; Mark Kester; David J Feith; Thomas P Loughran
Journal:  Blood Rev       Date:  2022-04-09       Impact factor: 10.626

Review 2.  Leukemic Stem Cell: A Mini-Review on Clinical Perspectives.

Authors:  Igor Valentim Barreto; Flávia Melo Cunha de Pinho Pessoa; Caio Bezerra Machado; Laudreísa da Costa Pantoja; Rodrigo Monteiro Ribeiro; Germison Silva Lopes; Maria Elisabete Amaral de Moraes; Manoel Odorico de Moraes Filho; Lucas Eduardo Botelho de Souza; Rommel Mário Rodriguez Burbano; André Salim Khayat; Caroline Aquino Moreira-Nunes
Journal:  Front Oncol       Date:  2022-06-24       Impact factor: 5.738

3.  The clinical relevance and prognostic significance of adenosine triphosphate ATP-binding cassette (ABCB5) and multidrug resistance (MDR1) genes expression in acute leukemia: an Egyptian study.

Authors:  Hala M Farawela; Mervat M Khorshied; Neemat M Kassem; Heba A Kassem; Hamdy M Zawam
Journal:  J Cancer Res Clin Oncol       Date:  2014-05-08       Impact factor: 4.553

4.  MBL-II-141, a chromone derivative, enhances irinotecan (CPT-11) anticancer efficiency in ABCG2-positive xenografts.

Authors:  Léa Payen; Mylène Honorat; Jérôme Guitton; Charlotte Gauthier; Charlotte Bouard; Florine Lecerf-Schmidt; Basile Peres; Raphaël Terreux; Héloïse Gervot; Catherine Rioufol; Ahcène Boumendjel; Alain Puisieux; Attilio Di Pietro
Journal:  Oncotarget       Date:  2014-12-15

Review 5.  Detection approaches for multidrug resistance genes of leukemia.

Authors:  Ying Du; Baoan Chen
Journal:  Drug Des Devel Ther       Date:  2017-04-18       Impact factor: 4.162

6.  Clinical and Prognostic Significance of Cell Sensitivity to Chemotherapy Detected in vitro on Treatment Response and Survival of Leukemia Patients.

Authors:  Maria Kolesnikova; Aleksandra Sen'kova; Sofia Tairova; Viktor Ovchinnikov; Tatiana Pospelova; Marina Zenkova
Journal:  J Pers Med       Date:  2019-05-07

7.  Modulation of Multidrug Resistance Gene Expression by Coumarin Derivatives in Human Leukemic Cells.

Authors:  Tomasz Kubrak; Anna Bogucka-Kocka; Łukasz Komsta; Daniel Załuski; Jacek Bogucki; Dariusz Galkowski; Robert Kaczmarczyk; Marcin Feldo; Maria Cioch; Janusz Kocki
Journal:  Oxid Med Cell Longev       Date:  2017-12-13       Impact factor: 6.543

8.  Development of Resistance to Endoplasmic Reticulum Stress-Inducing Agents in Mouse Leukemic L1210 Cells.

Authors:  Martin Cagala; Lucia Pavlikova; Mario Seres; Karolina Kadlecikova; Albert Breier; Zdena Sulova
Journal:  Molecules       Date:  2020-05-28       Impact factor: 4.411

9.  Successful second allogeneic stem-cell transplantation from the same sibling donor for a patient with recurrent hepatosplenic gamma-delta (γ/δ) T-cell lymphoma: A case report.

Authors:  Hui Pan; Jing Huang; Jun-Nan Li; Li Yang; Jian-Yu Wang; Xin Wang; Lin Liu; Ze-Song Yang; Li Wang
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

10.  Sorcin: a novel potential target in therapies of cancers.

Authors:  Xinyi Zhou; Xue Wu; Baoan Chen
Journal:  Cancer Manag Res       Date:  2019-08-05       Impact factor: 3.989
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.